Table 4 Adverse events experienced by patients in the study (n = 66)
From: Chemoradiation with capecitabine and mitomycin-C for stage I-III anal squamous cell carcinoma
Toxicity grade of adverse event | Number of patients (percent) N = 66 |
|---|---|
0 | 35 (53%) |
1 | 19 (29%) |
2 | 7 (11%) |
3 | 2 (3%) |
4 | 3 (5%) |
Case descriptions of grade 3 and 4 toxicity description (case by case) | |
Case 1, grade 3 | Grade 2 stomatitis, grade 3 diarrhea |
Case 2, grade 3 | Grade 3 diarrhea, stool incontinence |
Case 3, grade 4 | Grade 4 diarrhea |
Case 4, grade 4 | Grade 4 diarrhea, stool incontinence |
Case 5, grade 4 | Grade 4 diarrhea |